Korea Research Institute of Bioscience and Biotechnology;Enzychem Lifesciences Corporation
发明人:
Kim, Jae Wha,Oh, Sei Ryang,Ahn, Kyung Seop,Kang, Ho Bum,Shin, Jae Min,Ko, Young Eun,Lee, Tae Suk,Kim, Myung Hwan,Kang, Jong Koo,Han, Yong-Hae,Sohn, Ki-Young
申请号：
AU2014309635
公开号：
AU2014309635A1
申请日:
2014.08.18
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to a composition containing a monoacetyldiglyceride compound as an active ingredient, for inhibiting blood cancer or metastasis, and a use thereof. The monoacetyldiglyceride compound according to the present invention has excellent effects of inhibiting the expression of IL-4 and inhibiting the activity of STAT-6, and thereby is capable of overcoming side effects of currently used blood cancer or metastasis inhibiting agents. Also, the monoacetyldiglyceride compound is a non-toxic compound having superior therapeutic effects and thus can be useful as a composition for preventing, treating, or alleviating blood cancer and metastasis.
